Evotec (OTCMKTS:EVTCY) Hits New 52-Week Low – Here’s What Happened

Evotec SE (OTCMKTS:EVTCYGet Free Report)’s stock price reached a new 52-week low on Monday . The stock traded as low as $2.90 and last traded at $2.96, with a volume of 199176 shares changing hands. The stock had previously closed at $3.14.

Evotec Stock Down 2.0 %

The company has a debt-to-equity ratio of 0.53, a current ratio of 2.57 and a quick ratio of 2.50. The firm’s 50 day moving average is $3.38 and its two-hundred day moving average is $4.68. The firm has a market capitalization of $957.64 million, a P/E ratio of 7.07 and a beta of 0.98.

Evotec Company Profile

(Get Free Report)

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.

Read More

Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.